# A Mass Balance Study of [14C]ABSK011

> **NCT06896760** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Abbisko Therapeutics Co, Ltd** · enrollment: 6 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** [14C]ABSK011

## Key facts

- **NCT ID:** NCT06896760
- **Lead sponsor:** Abbisko Therapeutics Co, Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-07
- **Primary completion:** 2025-11-07
- **Final completion:** 2026-04-07
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06896760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06896760, "A Mass Balance Study of [14C]ABSK011". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06896760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*